Underuse of proven therapies including beta-blockers, ACE inhibitors, ARBs, and MRAs contributes to significant morbidity and mortality in patients with chronic heart failure.
Absolute Event Rate: 0% vs 0%
CHF is associated with significant morbidity and mortality due to associated co-morbidities and underuse of proven therapy like BBs, ACEIs or ARBs and MRAs. Careful attention to optimization of different drugs therapy in patients with CHF may help to improve patient outcomes.
Ghimire et al. (Sun,) reported a other. Underuse of proven therapies including beta-blockers, ACE inhibitors, ARBs, and MRAs contributes to significant morbidity and mortality in patients with chronic heart failure.